Novo Nordisk Chief Financial Officer: The outlook also reflects expectations for an increase in international business sales and a decline in sales in the US.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.